E-LIB Suche - Ergebnisse für: Holth Rustad, Even

1

PB2501: INSIGHT-1: A PHASE I FIRST-IN-HUMAN TCR TRIAL OF GE..:

Buechner, Jochen ; Holth Rustad, Even ; Meyer, Saskia...
HemaSphere. 7 (2023) S3 - p. e06642c9 , 2023

Link: https://doi.org/10.1097/..

2

PDL1 Expression on Plasma and Dendritic Cells in Myeloma Bo..:

Sponaas, Anne-Marit ; Moharrami, Neda Nejati ; Feyzi, Emadoldin...
PLOS ONE. 10 (2015) 10 - p. e0139867 , 2015

Link: https://doi.org/10.1371/..

3

Rituximab‐treated patients with lymphoma develop strong CD8..:

Riise, Jon ; Meyer, Saskia ; Blaas, Isaac...
British Journal of Haematology. 197 (2022) 6 - p. 697-708 , 2022

Link: https://doi.org/10.1111/..

4

Clonal evolution after treatment pressure in multiple myelo..:

Misund, Kristine ; Hofste op Bruinink, Davine ; Coward, Eivind...
Leukemia. 36 (2022) 7 - p. 1887-1897 , 2022

Link: https://doi.org/10.1038/..

5

Baseline VDJ clonotype detection using a targeted sequencin..:

Hultcrantz, Malin ; Rustad, Even Holth ; Yellapantula, Venkata...
Blood Cancer Journal. 10 (2020) 7 - p. , 2020

Link: https://doi.org/10.1038/..

6

Immunosuppressive adenosine - a novel treatment target for ..:

Yang, Rui ; Elsaadi, Samah ; Misund, Kristine...
Clinical Lymphoma Myeloma and Leukemia. 19 (2019) 10 - p. e137-e138 , 2019

Link: https://doi.org/10.1016/..

7

PD1 is expressed on exhausted T cells as well as virus spec..:

Sponaas, Anne-Marit ; Yang, Rui ; Rustad, Even Holth...
Oncotarget. 9 (2018) 62 - p. 32024-32035 , 2018

Link: https://doi.org/10.18632..

8

PB2501: INSIGHT-1: A PHASE I FIRST-IN-HUMAN TCR TRIAL OF GE..:

Buechner, Jochen ; Holth Rustad, Even ; Meyer, Saskia...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429543/. , 2023

Link: http://www.ncbi.nlm.nih...

9

Prevalent and immunodominant CD8 T cell epitopes are conser..:

Meyer, Saskia ; Blaas, Isaac ; Bollineni, Ravi Chand...
Cell reports. 2023, 42 (1), .. , 2023

Link: https://hdl.handle.net/1..

10

PB2501: INSIGHT-1: A PHASE I FIRST-IN-HUMAN TCR TRIAL OF GE..:

Jochen Buechner ; Even Holth Rustad ; Saskia Meyer...
http://journals.lww.com/10.1097/01.HS9.0000976704.06642.c9. , 2023

Link: https://doi.org/10.1097/..

11

Prevalent and immunodominant CD8 T cell epitopes are conser..:

Meyer, Saskia ; Blaas, Isaac ; Bollineni, Ravi Chand...
Meyer, Saskia Blaas, Isaac Bollineni, Ravi Chand Delic-Sarac, Marina Tran, Trung Knetter, Cathrine Dai, Kezheng Madssen, Torfinn Støve Vaage, John T. Gustavsen, Alice Yang, Weiwen Nissen-Meyer, Lise Sofie Haug Douvlataniotis, Karolos Laos, Maarja Nielsen, Morten Milek Thiede, Bernd Søraas, Arne Vasli Lund Lund-Johansen, Fridtjof Rustad, Even Holth Olweus, Johanna . Prevalent and immunodominant CD8 T cell epitopes are conserved in SARS-CoV-2 variants. Cell reports. 2023, 42(1). , 2023

Link: http://hdl.handle.net/10..

12

evenrus/adjusted_pop_cov: First release:

Even Holth Rustad
https://github.com/evenrus/adjusted_pop_cov/tree/v1.0.0. , 2022

Link: https://zenodo.org/recor..

13

Clonal evolution after treatment pressure in multiple myelo..:

Misund, Kristine ; Hofste op Bruinink, Davine ; Coward, Eivind...
Misund, Kristine Hofste op Bruinink, Davine Coward, Eivind Hoogenboezem, Remco M. Rustad, Even Holth Sanders, Mathijs A. Rye, Morten Beck Sponaas, Anne-Marit van der Holt, Bronno Zweegman, Sonja Hovig, Eivind Meza, Leonardo Zepeda Sundan, Anders Myklebost, Ola Sonneveld, Pieter Waage, Anders . Clonal evolution after treatment pressure in multiple myeloma: heterogenous genomic aberrations and transcriptomic convergence. Leukemia. 2022, 36(7), 1887-1897. , 2022

Link: http://hdl.handle.net/10..

14

Rituximab-treated patients with lymphoma develop strong CD8..:

Riise, Jon ; Meyer, Saskia ; Blaas, Isaac...
Riise, Jon Meyer, Saskia Blaas, Isaac Chopra, Adity Tran, Trung Delic-Sarac, Marina Hestdalen, Malu Lian Brodin, Ellen Elisabeth Rustad, Even Holth Dai, Ke-Zheng Vaage, John T. Nissen-Meyer, Lise Sofie Haug Sund, Fredrik Wader, Karin Fahl Bjørnevik, Anne Turid Meyer, Peter Albert Nygaard, Gro Owren König, Marton Smeland, Sigbjørn Lund-Johansen, Fridtjof Olweus, Johanna Kolstad, Arne . Rituximab-treated patients with lymphoma develop strong CD8 T-cell responses following COVID-19 vaccination. British Journal of Haematology. 2022, 197(6), 697-708. , 2022

Link: http://hdl.handle.net/10..

15

Rituximab-treated patients with lymphoma develop strong CD8..:

Riise, Jon ; Meyer, Saskia ; Blaas, Isaac...
British Journal of Haematology. 2022, 197 (6), 697-708.. , 2022

Link: https://hdl.handle.net/1..